(VIANEWS) – The NASDAQ ended the session with Novavax jumping 9.92% to $45.47 on Wednesday, after two consecutive sessions in a row of gains. NASDAQ dropped 0.15% to $11,053.08, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.
Today’s last reported volume for Novavax is 6354460, 8.05% above its average volume of 5880920.
Novavax’s last close was $41.37, 85.11% under its 52-week high of $277.80.
The company’s growth estimates for the present quarter and the next is 210.7% and 254.1%, respectively.
Year-on-year quarterly revenue growth declined by 20.5%, now sitting on 1.15B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Novavax’s stock is considered to be oversold (<=20).
Novavax’s Stock Yearly Top and Bottom Value
Novavax’s stock is valued at $45.47 at 18:23 EST, way under its 52-week high of $277.80 and way higher than its 52-week low of $34.88.
Novavax’s Moving Average
Novavax’s worth is way below its 50-day moving average of $50.63 and way under its 200-day moving average of $120.50.
More news about Novavax (NVAX).